Fortrea Holdings (FTRE) Retained Earnings (2023 - 2026)
Fortrea Holdings (FTRE) posted Retained Earnings of -$1.4 billion for Q1 2026, down 1.71% on a QoQ basis from -$1.4 billion in Q4 2025, and down 168.4% year-over-year from $2.1 billion in Q1 2025.
Fortrea Holdings (FTRE) Retained Earnings (2023 - 2026) Analysis & Trends
Fortrea Holdings' Retained Earnings history runs 4 years deep, the most recent figure standing at -$1.4 billion for Q1 2026.
- Quarterly Retained Earnings fell 168.4% year-over-year to -$1.4 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.4 billion (down 168.4% YoY) and the FY2025 annual result came in at -$1.4 billion, down 248.41% from the prior year.
- Retained Earnings was -$1.4 billion for Q1 2026 at Fortrea Holdings, down from -$1.4 billion in the prior quarter.
- Across five years, Retained Earnings topped out at $2.1 billion in Q1 2025 and bottomed at -$1.4 billion in Q1 2026.
- A 4-year average of $43.0 million and a median of -$196.8 million in 2023 frame the typical range for Retained Earnings.
- Peak annual rise in Retained Earnings reached 1313.45% in 2025, while the deepest fall reached 658.39% in 2025.
- Fortrea Holdings' Retained Earnings stood at -$215.5 million in 2023, then slumped by 84.22% to -$397.0 million in 2024, then slumped by 248.41% to -$1.4 billion in 2025, then declined by 1.71% to -$1.4 billion in 2026.
- Business Quant data shows FTRE's Retained Earnings at -$1.4 billion in Q1 2026, -$1.4 billion in Q4 2025, and -$1.4 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Fortrea Holdings | 1.83 Bn | 1.68 Bn | 123.60 Mn | -1.41 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.41 Bn |
| Dec 31, 2025 | -1.38 Bn |
| Sep 30, 2025 | -1.35 Bn |
| Jun 30, 2025 | -155.60 Mn |
| Mar 31, 2025 | 2.06 Bn |
| Dec 31, 2024 | -397.00 Mn |
| Sep 30, 2024 | -178.10 Mn |
| Jun 30, 2024 | -249.00 Mn |
| Mar 31, 2024 | -169.50 Mn |
| Dec 31, 2023 | -215.50 Mn |
| Sep 30, 2023 | 1.99 Bn |
| Jun 30, 2023 | 1.98 Bn |